Target stacking up on protein supplements while capitalizing on weight loss drug trend

The rapid adoption of GLP-1 weight loss medications — drugs like Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Zepbound and Mounjaro — is reshaping how Americans eat and shop. It’s also changing how major corporations do business.  From new product lines to expanding certain categories, companies are trying to capitalize on the lifestyle shifts prompted by […]